Drug price group slashes suggested price of Pfizer COVID treatment by 80%
Dec 20 (Reuters) - An influential drug pricing research group has cut its suggested price range for Pfizer Inc's PFE.NCOVID-19 antiviral treatment Paxlovid by more than 80%, partly to reflect the decreased disease…
